Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck to stop phase 3 trial of Keytruda plus Lynparza for lung cancer patients

Ruchika Sharma8 Dec 2023 3:19 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that it will stop the Phase 3 KEYLYNK-008 trial evaluating...

USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas Pharma

Pfizer, Valneva conclude recruitment for Phase 3 trial for Lyme Disease Vaccine candidate VLA15

Ruchika Sharma8 Dec 2023 2:30 PM IST

New York: Pfizer Inc. and Valneva SE have announced that they have completed recruitment for the Phase 3 trial Vaccine Against Lyme for Outdoor...

Sanofi to focus on 12 blockbuster drug candidates, immunology pipeline

Ruchika Sharma8 Dec 2023 1:30 PM IST

New Delhi: Sanofi said on Thursday it will focus on 12 potential blockbuster drug candidates and prioritise development in immunology, as it...

Genmab, AbbVie Face Setback as Epcoritamab Misses Survival Goal in Lymphoma Study

AbbVie to acquire Cerevel Therapeutics for USD 8.7 billion

Ruchika Sharma8 Dec 2023 12:30 PM IST

North Chicago: AbbVie Inc. and Cerevel Therapeutics have announced a definitive agreement under which AbbVie will acquire Cerevel Therapeutics and its...

Natco Pharma net profit down 23.44 percent at Rs 517.9 crore in Q2

Operations at Natco Pharma Chennai factory temporarily disrupted due to cyclone

Ruchika Sharma8 Dec 2023 11:30 AM IST

Hyderabad: Natco Pharma has announced that the operations at the Company's factory located at Manali Industrial Area, Chennai, Tamil Nadu have been...

USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers Squibb

Bristol Myers Squibb Abecma approved for use in earlier lines of therapy for patients with relapsed or refractory Multiple Myeloma in Japan

Ruchika Sharma7 Dec 2023 4:30 PM IST

Tokyo: Bristol-Myers Squibb K.K. has announced that the company has received manufacturing and marketing approval of the supplemental New Drug...

Merck in advanced talks to acquire SpringWorks

Merck KGaA multiple sclerosis drug fails in late-stage trials

Ruchika Sharma7 Dec 2023 3:30 PM IST

Frankfurt: Merck KGaA's experimental multiple sclerosis (MS) drug missed the primary goal in highly anticipated late-stage trials, dealing a...

Emcure wins dismissal of US lawsuit over COVID vaccine trade secrets

Ruchika Sharma7 Dec 2023 2:42 PM IST

The lawsuit said that HDT licensed its technology to Emcure subsidiary Gennova Biopharmaceuticals to develop and sell the vaccine in India. HDT...

USFDA concludes inspection at Dr Reddys Labs Srikakulam API facility

Dr Reddys Labs arm, Coya Therapeutics ink pact for Amyotrophic Lateral Sclerosis therapy COYA 302

Ruchika Sharma7 Dec 2023 1:30 PM IST

Dr Reddy's will make a USD 7.5 million upfront payment to Coya.

Bristol Myers Squibb Breyanzi approved by USFDA for adults with Marginal Zone Lymphoma

USFDA accepts for priority review Bristol Myers Squibb application for Opdivo plus Cisplatin-Based Chemotherapy for urothelial carcinoma

Ruchika Sharma7 Dec 2023 12:30 PM IST

Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License...

Caplin Steriles gets USFDA nod for Procainamide Hydrochloride Injection for treating abnormal heart rhythm

Novartis gets USFDA nod for Fabhalta for adults with paroxysmal nocturnal hemoglobinuria

Ruchika Sharma7 Dec 2023 11:43 AM IST

Basel: Novartis has announced that the U.S. Food and Drug Administration (FDA) has approved Fabhalta (iptacopan) as the first oral monotherapy for the...

Indoco Remedies CRO AnaCipher gets one Form 483 from USFDA

Indoco Remedies Canagliflozin Tablets for type 2 diabetes adults get USFDA tentative okay

Ruchika Sharma6 Dec 2023 5:01 PM IST

Canagliflozin improves glycemic control in adults with type 2 diabetes mellitus.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok